Life sciences has entered an era of computational scale, and for more than a decade, NVIDIA has built the full GPU-accelerated computing stack — spanning hardware, frameworks, libraries, models, microservices and domain-specific tools — to help researchers run more sophisticated workflows and iterate faster.
This week, Anthropic announced Claude Science, an AI workbench for science research that lets scientists converse with agents in natural language to run their work end to end.
Claude Science integrates with NVIDIA BioNeMo Agent Toolkit as a resource that scientists can access within their workflow. The toolkit packages NVIDIA-accelerated capabilities as callable skills, enabling Claude Science to select the appropriate tool, prepare valid inputs and execute the workflow — all while connecting to NVIDIA compute resources deployed anywhere. This brings NVIDIA’s accelerated models, libraries and NVIDIA NIM microservices directly into the same environment where the rest of the research happens.
The world’s largest pharmaceutical companies use NVIDIA technologies to advance AI-enabled research across drug discovery, genomics, medical imaging, molecular design and protein engineering. Today, 18 of the top 20 pharmaceutical companies use NVIDIA BioNeMo, underscoring the breadth of its role across the ecosystem.
